
TY  - JOUR
TI  - SYMPOSIA
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 12
IS  - s2
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.1999.tb00913.x
DO  - doi:10.1111/j.1468-3083.1999.tb00913.x
SP  - S3
EP  - S41
PY  - 1999
ER  - 

TY  - JOUR
TI  - SEPTEMBER 15, 2003–PLENARY LECTURES
JO  - Brain Pathology
VL  - 13
IS  - s1
SN  - 1015-6305
UR  - https://doi.org/10.1111/j.1750-3639.2003.tb00043.x
DO  - doi:10.1111/j.1750-3639.2003.tb00043.x
SP  - S1
EP  - S159
PY  - 2003
ER  - 

TY  - JOUR
TI  - 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 61
IS  - S2
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.25314
DO  - doi:10.1002/pbc.25314
SP  - S105
EP  - S433
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts—Poster
JO  - Alcoholism: Clinical and Experimental Research
VL  - 34
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2010.01210.x
DO  - doi:10.1111/j.1530-0277.2010.01210.x
SP  - 11A
EP  - 243A
PY  - 2010
ER  - 

TY  - JOUR
TI  - Arthritis & Rheumatism, 2001 Annual Scientific Meeting Abstracts, November 10–15, 2001, San Francisco, CA
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 44
IS  - S9
SN  - 0004-3591
UR  - https://doi.org/10.1002/1529-0131(200109)44:9+<::AID-ART426>3.0.CO;2-7
DO  - doi:10.1002/1529-0131(200109)44:9+<::AID-ART426>3.0.CO;2-7
SP  - 166
EP  - 276
PY  - 2001
AB  - Abstract Scientific Abstracts 679?1343
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology SIOP XXXXII Congress Boston, United States October 21–24, 2010 SIOP Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 55
IS  - 5
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.22779
DO  - doi:10.1002/pbc.22779
SP  - 775
EP  - 1014
PY  - 2010
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 19
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.15405
DO  - doi:10.1111/ajt.15405
SP  - 310
EP  - 590
PY  - 2019
ER  - 

TY  - JOUR
AU  - Sugerman, PB
AU  - Joseph, BK
AU  - Savage, NW
TI  - The role of oncogenes, tumour suppressor genes and growth factors in oral squamous cell carcinoma: a case of apoptosis versus proliferation
JO  - Oral Diseases
VL  - 1
IS  - 3
SN  - 1354-523X
UR  - https://doi.org/10.1111/j.1601-0825.1995.tb00181.x
DO  - doi:10.1111/j.1601-0825.1995.tb00181.x
SP  - 172
EP  - 188
KW  - oral carcinoma
KW  - oncogenes: tumour-suppressor genes
KW  - apoptosis
PY  - 1995
AB  - Mutation, deactivation and disregulated expression of oncogenes and tumour-suppressor genes may be involved in the pathogenesis of oral squamous cell carcinoma (SCC). Deactivation of the p53 tumour-suppressor gene allows cell proliferation and blocks apoptosis of malignant oral keratinocytes. Mutation in the ras oncog-ene results in persistent mitogenic signalling. Upregul-ated c-Myc expression, in the presence of growth factors, provides an additional proliferative signal. Loss of retino-blastoma tumour-suppressor gene (Rb) function may contribute to oral keratinocyte hyperproliferation and recent evidence suggests that simultaneous deactivation of both p53 and Rb is required for tumourigenesis. Enhanced Bcl-2 and reduced Fas expression inhibit tumour cell apoptosis and may convey resistance to cyto-toxic drugs and T cell-mediated cytotoxicity, respectively. Exogenous mutagens such as tobacco, alcohol and viral oncogenes may cause altered expression of oncogenes and tumour-suppressor genes in some cases of oral SCC. The impact of these mechanisms on future therapies for oral SCC is highlighted.
ER  - 

TY  - JOUR
AU  - Whittingham, S.
AU  - Mackay, I. R.
TI  - Tissue Antigens: Autoantigens, Ailoantigens, Xenoantigens and Neoantigens*
JO  - Australian and New Zealand Journal of Medicine
VL  - 7
IS  - 2
SN  - 0004-8291
UR  - https://doi.org/10.1111/j.1445-5994.1977.tb04689.x
DO  - doi:10.1111/j.1445-5994.1977.tb04689.x
SP  - 172
EP  - 194
PY  - 1977
AB  - Summary: The subject of Clinical Immunology is developing hand in hand with a wide and rapidly moving area of laboratory technology. The result is a better understanding of autoimmune disease, tissue transplantation rejection, foetal-maternal incompatibility, allergic disease, immunodeficiency disorders, adverse reactions to drugs, aberrant responses to bacterial and viral infections, and growth and spread of malignant cells. Basic to this understanding is the need to appreciate the character and composition of natural substances which act as immunogens and elicit antibodies. These substances have, according to their origin, been classified as autoantigens, ailoantigens, xenoantigens and neoantigens. This review summarizes our knowledge relating to such antigens, emphasizing those aspects relevant to human disease and pointing to the major gaps that future research must bridge.
ER  - 

TY  - JOUR
TI  - 2016 Annual Meeting of the American Society for Bone and Mineral Research Atlanta, GA September 16–19, 2016
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 31
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.3107
DO  - doi:10.1002/jbmr.3107
SP  - S1
EP  - S411
PY  - 2016
ER  - 

TY  - JOUR
AU  - Derenski, Karrie
AU  - Catlin, Jennifer
AU  - Allen, Livia
TI  - Parenteral Nutrition Basics for the Clinician Caring for the Adult Patient
JO  - Nutrition in Clinical Practice
JA  - Nutrition in Clinical Practice
VL  - 31
IS  - 5
SN  - 0884-5336
UR  - https://doi.org/10.1177/0884533616657650
DO  - doi:10.1177/0884533616657650
SP  - 578
EP  - 595
KW  - nutritional support
KW  - parenteral nutrition solutions
KW  - central venous catheters
KW  - vascular access devices
PY  - 2016
AB  - Parenteral nutrition (PN) is a life-sustaining therapy providing nutrients to individuals with impaired intestinal tract function and enteral access challenges. It is one of the most complex prescriptions written routinely in the hospital and home care settings. This article is to aid the nutrition support clinician in the safe provision of PN, including selecting appropriate patients for PN, vascular access, development of a PN admixture, appropriate therapy monitoring, recognition of preparation options, and awareness of preparation and stability concerns.
ER  - 

TY  - JOUR
TI  - Posters
JO  - Transplant International
JA  - Transpl Int
VL  - 26
IS  - s2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.12214
DO  - doi:10.1111/tri.12214
SP  - 185
EP  - 339
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - International Journal of Stroke
JA  - Int J Stroke
VL  - 9
IS  - S3
SN  - 1747-4930
UR  - https://doi.org/10.1111/ijs.12367
DO  - doi:10.1111/ijs.12367
SP  - 41
EP  - 331
PY  - 2014
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Asia-Pacific Journal of Clinical Oncology
JA  - Asia‐Pac J Clin Oncol
VL  - 10
IS  - S8
SN  - 1743-7555
UR  - https://doi.org/10.1111/ajco.12304
DO  - doi:10.1111/ajco.12304
SP  - 77
EP  - 124
PY  - 2014
ER  - 

TY  - JOUR
TI  - Colorectal Surgery Program Abstracts
JO  - ANZ Journal of Surgery
JA  - ANZ J Surg
VL  - 83
IS  - S1
SN  - 1445-1433
UR  - https://doi.org/10.1111/ans.12144
DO  - doi:10.1111/ans.12144
SP  - 21
EP  - 38
PY  - 2013
ER  - 

TY  - JOUR
TI  - 2015 ACR/ARHP Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatology
JA  - Arthritis & Rheumatology
VL  - 67
IS  - S10
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.39448
DO  - doi:10.1002/art.39448
SP  - 1
EP  - 4046
PY  - 2015
AB  - For a searchable version of these abstracts, please visit www.acrabstracts.org. Please Note: It may take several minutes for this file to download.
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 301–2389)
JO  - Hepatology
JA  - Hepatology
VL  - 68
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30257
DO  - doi:10.1002/hep.30257
SP  - 184
EP  - 1353
PY  - 2018
ER  - 

TY  - JOUR
TI  - International Society of Paediatric Oncology, SIOP XXXVI Congress Meeting: Abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 43
IS  - 4
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.20119
DO  - doi:10.1002/pbc.20119
SP  - 305
EP  - 503
PY  - 2004
ER  - 

TY  - JOUR
TI  - Concurrent Session
JO  - The Journal of Dermatology
VL  - 39
IS  - s1
SN  - 0385-2407
UR  - https://doi.org/10.1111/j.1346-8138.2012.01623.x
DO  - doi:10.1111/j.1346-8138.2012.01623.x
SP  - 12
EP  - 52
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
VL  - 74
IS  - S1
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.1998.tb05472.x
DO  - doi:10.1111/j.1423-0410.1998.tb05472.x
SP  - 1
EP  - 191
PY  - 1998
ER  - 
